# Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

> Research article (American Journal of Hematology, 2021) · cited 57× · AI/ML

**Wikidata**: [openalex:W3207985070](https://www.wikidata.org/wiki/openalex:W3207985070)  
**Source**: https://4ort.xyz/entity/roxadustat-for-the-treatment-of-anemia-in-patients-with-scp-lowerrisk-scp-myelodysplastic-syndrome-openlabel-doseselecti